WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of SIGMA ALDRICH CP (SIAL)

Name SIGMA ALDRICH CP
Year low 56.18
Year High 76.16
Symbol SIAL
Last trade 71.32
Percentage change 0.00
Volume 0
Media Volume (3m) 683,937
PE Ratio 19.81
EPS 3.60
Market Cap 8590
Media fatt 2526
Trend fatt trend fatt graph for SIGMA ALDRICH CP
Media net income 465
Trend net income trend net income for SIGMA ALDRICH CP
P / E P / E graph for SIGMA ALDRICH CP - 12 points 12
EPS EPS graph for SIGMA ALDRICH CP - 15 points 15
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for SIGMA ALDRICH CP - 2 points 2
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for SIGMA ALDRICH CP - 6 points 6
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for SIGMA ALDRICH CP - 7 points 7
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for SIGMA ALDRICH CP - 13 points 13
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for SIGMA ALDRICH CP - 3 points 3
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for SIGMA ALDRICH CP - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for SIGMA ALDRICH CP - 5 points 5
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for SIGMA ALDRICH CP - 4 points 4
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for SIGMA ALDRICH CP - 5 points 5
. . graph for SIGMA ALDRICH CP - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for SIGMA ALDRICH CP - 1 points 1
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for SIGMA ALDRICH CP - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for SIGMA ALDRICH CP - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for SIGMA ALDRICH CP - 1 points 1
. . graph for SIGMA ALDRICH CP - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for SIGMA ALDRICH CP - 0 points 0
SINTESE 78

GRAPHS

max price logarithm graph for SIGMA ALDRICH CP based on no conditions max volume linear graph for SIGMA ALDRICH CP based on no conditions

News

Sigma-Aldrich: Upside Potential Outweighs Downside Risk At The Current Price (Feb 06 - reuters) Sigma-Aldrich Passes This Key Test (Feb 06 - reuters) » More SIAL.MW Market Views (Feb 05 - reuters) » More SIAL.A Market Views (Feb 04 - reuters) Sigma-Aldrich Completes Acquisition of BioReliance (Feb 01 - reuters) Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences (Jan 28 - reuters) » More SIAL.DF Market Views (Jan 14 - reuters) In Search Of Rising Dividends: Sigma Aldrich (Jan 13 - reuters) Sigma-Aldrich Corporation Announces Q4 Conference Call (Jan 11 - reuters) UPDATE 1-Sigma-Aldrich to buy testing services co for $350 mln (Jan 09 - reuters) Avista Capital Partners Agrees to Sell BioReliance to Sigma-Aldrich Corporation (Jan 09 - reuters) Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services (Jan 09 - reuters) Sigma-Aldrich Corporation to Present at Upcoming Investor Conference (Jan 09 - reuters) Sigma® Life Science Announces Gene Knockout Rat Models for Cardiovascular, Diabetes and Atherosclerosis Research (Jan 09 - reuters) Sigma® Life Science, Autism Speaks to Present Key Data on the Behavior of the First Knockout Rat Models of Autism (Jan 09 - reuters) Sigma-Aldrich (NASDAQ: SIAL) Declares Quarterly Dividend. (Jan 09 - reuters) Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences (Jan 09 - reuters) SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line (Jan 09 - reuters) SAFC Verona HPAPI Manufacturing Facility Receives SafeBridge Certification (Jan 09 - reuters) Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. (Jan 09 - reuters) Stellar Biotechnologies Announces a Strategic Agreement for Marketing and Sales With SAFC(R) (Aug 03 - reuters) Sigma® Life Science Reaches Milestone in Gene Editing with Increased Affordability for CompoZr® ZFNs and the Expansion of Knockout ZFNs to Include Every Gene in Mice and Rats (Aug 03 - reuters) Sigma-Aldrich's CEO Discusses Q2 2011 Results - Earnings Call Transcript (Jul 27 - reuters) Sigma-Aldrich (NASDAQ:SIAL) Q2 2011 Sales Achieve New Quarterly High. Reported Sales and EPS Increase 15% Compared to 2010. Full Year 2011 Diluted Adjusted EPS Expectation Affirmed at $3.60 to $3.75. (Jul 26 - reuters) Here's Why Techne's Earnings Are Worse Than They Look (Jul 22 - reuters) Sigma® Life Science Launches Genetically Modified Human Cell Lines for Breast Cancer Research (Jul 22 - reuters) Sigma® Life Science Launches CompoZr® Targeted Integration Kit - mRosa26 for the Mouse Genome (Jul 19 - reuters) » More SIAL.O Market Views (Jul 15 - reuters) SAFC Launches CHOZN ZFN-modified CHO Cell Lines to Enhance Speed of Bioproduction (Jul 07 - reuters) Sigma-Aldrich Corporation Announces Q2 2011 Conference Call (Jun 27 - reuters) Hydrogen Storage Collaboration Between Sigma-Aldrich and Ilika Technologies to Scale-up and Commercialize Boron Hydride Materials (Jun 07 - reuters) Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences (Jun 01 - reuters) Aldrich Materials Science Endows New Materials Research Society Mid-Career Researcher Award (May 25 - reuters) Sigma-Aldrich Acquires Vetec Quimica Fina Ltda (May 24 - reuters) » More SIAL.A Market Views (May 12 - reuters) » More SIAL.MW Market Views (May 06 - reuters) Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology (May 05 - reuters) Sigma-Aldrich (NASDAQ:SIAL) Declares Quarterly Dividend (May 04 - reuters) Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences (May 02 - reuters) » More SIAL.DF Market Views (Apr 29 - reuters) Sigma-Aldrich's CEO Discusses Q1 2011 Results - Earnings Call Transcript (Apr 27 - reuters) Sigma-Aldrich (NASDAQ:SIAL) Reports Q1 2011 Diluted EPS of $0.97, a 20% Increase Over Q1 2010. Q1 2011 Sales and Earnings Achieve New Quarterly High. Full Year 2011 Diluted Adjusted EPS Expectation Raised to $3.60 to $3.75. (Apr 26 - reuters) Sigma-Aldrich Corporation Annual Shareholder's Meeting (Apr 19 - reuters) » More SIAL.O Market Views (Apr 15 - reuters) Here's How Techne Is Making so Much for You (Apr 15 - reuters) Why Balchem's Earnings Are Outstanding (Apr 15 - reuters) 10 Best S&P 500 Dividend Aristorcrat Growth Stocks (Apr 15 - reuters) Sigma® Life Science and Kraig Biocraft Laboratories to Develop Silkworms for the Production of Spider Silk (Apr 15 - reuters) Sigma-Aldrich and Kraig Biocraft Laboratories Successfully Negotiate License Agreement (Apr 15 - reuters) Sigma-Aldrich Corporation Announces Q1 2011 Earnings Conference Call (Apr 15 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY